Advanced Space exists to support the sustainable exploration, development, and settlement of space. We respect the past, believe nothing is sacred, and understand that fundamentals change. Our core business is focused on supporting and improving mission planning and operations. Advanced Space has core technical competencies in dynamics, estimation, and control which are leveraged by a dynamic, flexible, and agile team with cross domain knowledge. The company is actively supporting mission and technology development efforts spanning commercial, civil, and national security customers.

Airdna provides data and analytics to vacation rental entrepreneurs and investors. Trusted by industry leaders such as Bank of America Merrill Lynch, CBRE, and UBS, Airdna tracks the daily performance of over 3,200,000 Airbnb listings worldwide to better understand the disruption and opportunities that the growing short-term rental industry is creating.

Ampt serves the global market for large-scale PV systems where reliability, predictability, scalability, efficiency, cost and control are paramount. We deliver power conversion electronics and information technology designed to reduce the cost and increase the efficiency of solar energy generation. Our technology enables active j-boxes for module makers, a new class of lower cost, higher efficiency inverters for inverter manufacturers, and lowest cost cabling and monitoring solutions for balance of system and O&M providers.

ANDE is the global leader in Rapid DNA technology. We are committed to designing Rapid DNA Analysis products and services for use by non-technical operators outside of a laboratory setting.

Apto is a web-based broker software for managing contacts, properties, listings, and deals for the commercial real estate industry. Its platform streamlines the full lifecycle of deals from prospect to close with sales tools that put their data to work and make sure no details fall through the cracks to consolidate, organize and securely store contact and property data in the cloud, that enables clients to find, win, and execute deals more efficiently and effectively.

ARB Midstream is an independent, growth-oriented company, providing complete midstream and marketing solutions for crude oil, LPGs and refined products. ARB leverages the unique knowledge and depth of experience of its personnel to develop midstream assets that resolve infrastructure bottlenecks in the most profitable North American oil plays. ARB's strategy centers around an "analyze, identify, execute, operate"​ philosophy: Analyze: ARB's strategy is rooted in understanding the fundamental analytics that both predict the near- and long-term disruptions in the market, and challenge and clarify the outlook for individual projects. The company's analytics are complemented by the extensive industry experience of its leadership team. Identify: ARB uses analytics to pinpoint infrastructure bottlenecks and under-served regions that are backed by oil plays with long-term, sustainable production economics.

We are Artifact Uprising. We create joy by helping you honor the meaningful in your life through printed photo gifts, books, and more. With a focus on high quality and elevated design, we hope to make permanence of what matters most.

Ascent360 partners with B2C marketers to simplify today’s increasingly complex data world and enable authentic relationships with prospects and customers. Our Customer Data Platform (CDP) creates a single source of truth from your siloed data sources. Then we provide marketing guidance to develop successful revenue-generating campaigns that increase engagement and maximize lifetime value.

Engineering expertise for better fiber networks. Building a new fiber broadband network requires careful planning. Each project varies in materials, geography, regulations, size and scale. To adapt to these unknowns, Biarri Networks has developed processes and tools that create better designs in the earliest stages of network construction planning. We’re pioneers in autodesign, a technique that produces more accurate network planning for bringing broadband networks to market years sooner—and at less cost per home passed—than traditional fiber network planning methods.

BiggerPockets is the largest online community and complete resource for anyone looking to succeed in real estate investing. With over 1,000,000 members, an abundance of forum posts, and limitless content, we aim to empower anyone interested in building wealth through real estate. Whether you’re just starting out, have a few deals under your belt, or are a seasoned veteran, BiggerPockets can help. We offer everything from networking opportunities, deal analysis tools, and courses to educational books, a top-rated podcast, and more. Our goal is to provide everyone with the resources and support they need to find their own success — whether that’s quitting a job to invest or simply creating additional passive income.

BillingPlatform provides a cloud-based platform that simplifies complex billing, automating quote-to-cash processes.

Biodesix is a molecular diagnostics company advancing the development of innovative products for personalizing medicine. The company provides physicians with diagnostic tests for earlier disease detection, more accurate diagnosis, disease monitoring and better therapeutic guidance, which may lead to improved patient outcomes. Biodesix discovers, develops and commercializes multivariate protein diagnostics based on their proprietary mass spectrometry-based discovery platform. VeriStrat, a multivariate serum protein test, is Biodesix’ first product developed with this technology. The commercially available test provides oncologists with information to help them select between erlotinib and single-agent chemotherapy for advanced lung cancer patients. Tests are processed in Biodesix’ CLIA-certified laboratory and results are reported in less than 72 hours. In addition to developing novel diagnostics independently, the company also partners with biotechnology and pharmaceutical companies to develop companion diagnostics to improve utility of therapeutic agents.